Navigation Links
Ameritox Receives Accreditation from College of American Pathologists
Date:9/27/2013

BALTIMORE, Sept. 27, 2013 /PRNewswire/ -- Ameritox has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) for a second time, based on the results of recent onsite inspections of its laboratories.

(Logo: http://photos.prnewswire.com/prnh/20130927/PH87582LOGO )

Ameritox Chief Laboratory Officer Jay Zimmerman was advised of this national recognition and congratulated for the excellence of the services being provided. Ameritox is one of more than 7,000 CAP-accredited laboratories worldwide.

"By meeting CAP standards, we have demonstrated to our customers that their samples are evaluated using top-notch laboratory equipment and service, and having CAP affirm that is very important to us," Zimmerman said.

The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the federal government as being equal to or more stringent than the government's own inspection program.

During the CAP accreditation process, inspectors examine the laboratory's records and quality control procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, as well as the laboratory's equipment, facilities, safety program and record, in addition to the overall management of the laboratory.  This stringent inspection program is designed specifically to ensure the highest standard of care for all laboratory patients.

"CAP is an advocate for high-quality patient care, and so is Ameritox," said Zimmerman. "We know that physicians must have confidence in the accuracy of the results we provide, so they can better monitor their patients' health."

About the College of American Pathologists 
As the leading organization for board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. With more than 18,000 physician members, the CAP has led as the gold standard in laboratory accreditation for more than 50 years with more than 7,500 CAP-accredited laboratories in 50 countries. Find more information about the CAP at cap.org. Follow CAP on Twitter at @pathologists.

About Ameritox

Ameritox is the nation's leader in Pain Medication Monitoring SolutionsSM, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with the information and support they need to enhance and optimize the care of chronic pain patients. Monitoring through prescription drug testing can help physicians make more informed clinical decisions while also helping to reduce the possible risk of misuse, abuse or diversion of powerful medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at www.youtube.com/ameritox.

Ameritox, Ameritox-Medication Monitoring Solutions, Rx Guardian, Rx Guardian INSIGHT and Rx Guardian CD are trademarks of Ameritox. Other trademarks are the property of their owners.

Contact: 
Joe Schramm 
800-323-4040, ext. 7445 

Read more news from Ameritox.


'/>"/>
SOURCE Ameritox
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Serial Entrepreneur, Rudy Mazzocchi, Receives Global Business Recognition Award as the 2013 Entrepreneur of the Year
2. Histogen’s Composition for Hair Growth Receives US Patent
3. Profound Medical Receives IDE Approval from FDA to Conduct TULSA Clinical Trial for New Treatment for Localized Prostate Cancer
4. Nasseo’s TiArray™ Dental Implant System Receives FDA Approval
5. Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants
6. BioLineRxs BL-8040 Receives Orphan Drug Designation for Treatment of AML
7. Histogen’s Method of Generating Multipotent Stem Cells Receives US Patent
8. Spartan Bioscience Receives FDA Clearance for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs
9. Medasense Receives Patent Approval for Novel Pain-Monitoring System
10. Wayne State receives National Science Foundation grant for training future nanoengineers
11. UMass Boston Receives $1 Million Grant to Recruit Urban Nurse Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
(Date:10/11/2017)... ... 2017 , ... Personal eye wash is a basic first aid supply for any work environment, ... eye do you rinse first if a dangerous substance enters both eyes? It’s one less ... with its unique dual eye piece. , “Whether its dirt and debris, or an acid ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):